Science for a better life
Bayer is committed to working with cancer agencies and drug plans to bring innovative tumour agnostic treatment to Canadian patients
Bayer to advance two first-of-its-kind cell and gene therapies for Parkinson’s disease
Bayer brings “Feeding a Hungry Planet” into focus by inviting young leaders from Canada to apply for the 5th biennial Youth Ag Summit
Bayer’s finerenone meets primary endpoint in Phase III FIGARO-DKD cardiovascular outcomes study in patients with chronic kidney disease and type 2 diabetes
Bayer Fund Launches 2021 Opportunity Scholarship Program for Students
We research, develop and market innovative products that improve the health of people and plants. Our business comprises three core divisions and one business unit. Learn more about it here.